© 1989 Oxford University Press
research-article |
A Population-Based Case-Control Study of Temporal Arteritis: Evidence for an Association between Temporal Arteritis and Degenerative Vascular Disease?
*Department of Health Sciences Research, Section of Clinical Epidemiology.
**The Department of Internal Medicine, Division of Rheumatology and Internal Medicine.
Department of Health Sciences Research, Section of Biostatistics, Mayo Clinic and Mayo Foundation Rochester MN 55905, USA.
Machado E B V (Department of Health Sciences Research, Section of Clinical Epidemiology, Mayo Clinic and Mayo Foundation, Rochester, MN 55905, USA), Gabriel S E, Beard C M, Michet C J, O'Fallon W M and Ballard D J. A population-based case-control study of temporal arteritis (TA): Evidence for an association between TA and degenerative vascular disease? International Journal of Epidemiology 1989, 18: 836–841.
The first population-based incident case-control study of temporal arteritis (TA) in the US was conducted using the unique data resources of the Rochester Epidemiology Project. During the period 1950–1985, 88 newly diagnosed cases of biopsy-proven TA were identified among residents of Olmsted County, Minnesota. Cases were each matched to four Olmsted County community controls on age, sex and duration of community medical record. Odds ratios (OR) were calculated for marital status, education, Quetelet index, pregnancy, age at menopause, thyroid disease, diabetes, smoking, hypertension, angina, myocardial infarction, peripheral vascular disease, and stroke. Multivariable conditional logistic regression analysis identified statistically significant adjusted OR for smoking (2.3, 95% CI = 1.3–4.1). Elevated ORs which were not statistically significant were noted for angina, myocardial infarction, and peripheral vascular disease. These data suggest that TA and arteriosclerosis may share a common causal pathway. Alternatively, histopathological misclassification of temporal artery biopsies may have resulted in the observed association. Due to the limited power of this population-based study, multicentre collaboration should be encouraged to more precisely define the epidemiology of TA.
Revised 1 April 1989
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  P. Porcu, O. Chavanon, F. Thony, and D. Blin Unusual aortic stent complication after endovascular repair of the descending thoracic aorta in type B dissection in a patient with giant-cell arteritis Interactive CardioVascular and Thoracic Surgery, February 1, 2009; 8(2): 287 - 289. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K Larsson, D Mellstrom, C Nordborg, A Oden, and E Nordborg Early menopause, low body mass index, and smoking are independent risk factors for developing giant cell arteritis Ann Rheum Dis, April 1, 2006; 65(4): 529 - 532. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J G Ray, M M Mamdani, and W H Geerts Giant cell arteritis and cardiovascular disease in older adults Heart, March 1, 2005; 91(3): 324 - 328. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M Lopez-Hoyos, M J Bartolome-Pacheco, R Blanco, V Rodriguez-Valverde, and V M Martinez-Taboada Selective T cell receptor decrease in peripheral blood T lymphocytes of patients with polymyalgia rheumatica and giant cell arteritis Ann Rheum Dis, January 1, 2004; 63(1): 54 - 60. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. M. Martinez-Taboada, M. J. Bartolome, M. D. Fernandez-Gonzalez, R. Blanco, V. Rodriguez-Valverde, and M. Lopez-Hoyos Homocysteine levels in polymyalgia rheumatica and giant cell arteritis: influence of corticosteroid therapy Rheumatology, September 1, 2003; 42(9): 1055 - 1061. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Nordborg and C. Nordborg Giant cell arteritis: epidemiological clues to its pathogenesis and an update on its treatment Rheumatology, March 1, 2003; 42(3): 413 - 421. [Abstract] [Full Text] [PDF]
|
|